Archive for the 'Genetics' Category


New Gene Therapy Methods Accurately Correct Mutation In Patient’s Stem Cells, Bringing Personalized Cell Therapies One Step Closer

For the first time, scientists have cleanly corrected a human gene mutation in a patient’s stem cells. The result, reported in Nature, brings the possibility of patient-specific therapies closer to becoming a reality…


(more...)


Cannabis Genetic Code Unlocked Paving Way To New Global Innovations

Sequencing of the entire genomes of the cannabis species Cannabis sativa and Cannabis indica, equating to some 131 billion base pairs of genetic data have been published this week…


(more...)


Talecris Biotherapeutics Study Demonstrates PROLASTIN®-C Is As Effective As PROLASTIN®

Talecris Biotherapeutics (Nasdaq: TLCR) announced the publication of results from a study showing that PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]) (A1PI) is as effective as PROLASTIN® (Alpha1-Proteinase Inhibitor [Human]) in raising levels of alpha-1 protein in patients with alpha1-antitrypsin (AAT) deficiency...
(more...)


Tibetans Have Mutations In Numerous Genes Related To How The Body Uses Oxygen

A comparison of the genomes of 50 Tibetans and 40 Han Chinese shows that ethnic Tibetans split off from the Han less than 3,000 years ago and since then rapidly evolved a unique ability to thrive at high altitudes and low oxygen levels...
(more...)


Genome-Wide Study Identifies Factors That May Affect Vitamin D Levels

An international research consortium has identified four common gene variants that are associated with blood levels of vitamin D and with an increased risk of vitamin D deficiency. The report from the SUNLIGHT consortium - involving investigators from six countries - will appear in The Lancet and is receiving early online release...
(more...)


The Genetic Secrets That Allow Tibetans To Thrive In Thin Air

A new study pinpoints the genetic changes that enable Tibetans to thrive at altitudes where others get sick. In the online edition of Proceedings of the National Academy of Sciences, an international team has identified a gene that allows Tibetans to live and work more than two miles above sea level without getting altitude sickness...
(more...)


FDA Approves New Treatment For Late-Onset Pompe Disease

The U.S. Food and Drug Administration approved Lumizyme (alglucosidase alfa) for patients ages 8 years and older with late-onset (non-infantile) Pompe disease, a rare genetic disorder. Pompe disease occurs in an estimated 1 in every 40,000 to 300,000 births. Its primary symptom is heart and skeletal muscle weakness, progressing to respiratory weakness and death from respiratory failure...
(more...)


Adapting To Life At High Elevations: Study Identifies 10 Genes Unique To Residents Of The Tibetan Highlands

Researchers have long wondered why the people of the Tibetan Highlands can live at elevations that cause some humans to become life-threateningly ill - and a new study answers that mystery, in part, by showing that through thousands of years of natural selection, those hardy inhabitants of south-central Asia evolved 10 unique oxygen-processing genes that help them live in higher climes...
(more...)


Gene Therapy May Be Effective In Treating PAH

Gene therapy has been shown to have positive effects in rat models of pulmonary arterial hypertension (PAH), according to researchers at the University of Adelaide in Australia. PAH is a life-threatening disease in which pressure in the blood vessels of the lungs increases, causing a back-pressure strain on the heart...
(more...)


Gene Therapy Trial Succeeds In Spurring Production Of A Protective Protein

Researchers at the University of Massachusetts Medical School and the University of Florida in Gainesville have safely given new, functional genes to patients with a hereditary defect that can lead to fatal lung and liver diseases, according to clinical trial findings slated to appear this week in the online early edition of the Proceedings of the National Academy of Science.
(more...)